• You need to sign in or sign up before continuing.
Close
https://www.astrazeneca.com/media-centre/press-releases/2023/agreement-with-eccogene-for-clinical-stage-glp-1ra.html
0
0
AstraZeneca licenses novel agent for the treatment of cardiometabolic conditions and obesity - AstraZeneca
11/9/23 at 7:05am
Organization
Astrazeneca.com
13 words
0
Comments
You are the first to view
Create an account or login to join the discussion